Po-Lin Lin Selected Research

carfilzomib

1/2020	Cytoplasmic, but not nuclear Nrf2 expression, is associated with inferior survival and relapse rate and response to platinum-based chemotherapy in non-small cell lung cancer.
5/2018	PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2.
1/2016	Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Po-Lin Lin Research Topics

Disease

16	Neoplasms (Cancer) 01/2020 - 08/2013
13	Heart Failure 03/2024 - 01/2021
7	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2014
6	Atrial Fibrillation 10/2023 - 01/2019
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2015
3	Stroke (Strokes) 03/2023 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
3	Thromboembolism 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 03/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2017 - 05/2016
2	Lung Neoplasms (Lung Cancer) 05/2016 - 08/2013
2	Colonic Neoplasms (Colon Cancer) 04/2016 - 02/2016
1	Type 2 Diabetes Mellitus (MODY) 12/2023
1	Peripheral Arterial Disease 03/2023
1	Chronic Limb-Threatening Ischemia 03/2023
1	Cicatrix (Scar) 01/2023
1	Anemia 01/2023
1	Infections 01/2023
1	Essential Hypertension 02/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Diabetes Mellitus 01/2021
1	Overweight 02/2020
1	Weight Loss (Weight Reduction) 02/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Carcinogenesis 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2017
1	Pathologic Constriction (Stenosis) 01/2016
1	Persistent Infection 08/2013
1	Adenocarcinoma of Lung 08/2013

Drug/Important Bio-Agent (IBA)

6	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2022 - 01/2021
5	RivaroxabanIBA 10/2023 - 01/2021
5	CateninsIBA 05/2018 - 10/2014
5	Messenger RNA (mRNA)IBA 01/2018 - 08/2013
3	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2021
3	IvabradineIBA 10/2021 - 01/2021
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2015
3	carfilzomibIBA 01/2020 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2015
3	XAV939IBA 04/2016 - 01/2016
2	Anti-Arrhythmia AgentsIBA 07/2021 - 01/2019
2	Dronedarone FDA Link 07/2021 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 05/2018
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 11/2017
2	TL 1IBA 09/2017 - 05/2016
2	Oncogene Proteins (Oncogene Protein)IBA 09/2017 - 05/2016
1	Natriuretic PeptidesIBA 03/2024
1	Sodium-Glucose Transport ProteinsIBA 12/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023
1	CanagliflozinIBA 12/2023
1	IronIBA 01/2023
1	Enalapril FDA LinkGeneric 01/2022
1	Propafenone (Rythmol)FDA LinkGeneric 07/2021
1	Amiodarone (Amiodarona)FDA LinkGeneric 07/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	lorcaserinIBA 02/2020
1	PlatinumIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	LigandsIBA 01/2018
1	hepatitis B virus X proteinIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	B7-H1 AntigenIBA 11/2017
1	VaccinesIBA 09/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	perifosineIBA 04/2016
1	3- (3- chlorophenoxymethyl)- 1- (tetrahydropyran- 4- yl)- 1H- pyrazolo(3,4- d)pyrimidin- 4- ylamineIBA 02/2016
1	Adenosine (Adenocard)FDA LinkGeneric 01/2016
1	MicroRNAs (MicroRNA)IBA 12/2015
1	Serine (L-Serine)FDA Link 04/2015
1	PaxillinIBA 04/2015
1	Interleukin-10 (Interleukin 10)IBA 08/2013

Therapy/Procedure

6	Therapeutics 05/2023 - 01/2021
4	Drug Therapy (Chemotherapy) 01/2020 - 08/2013
2	Catheter Ablation 03/2023 - 01/2022
2	Denervation 02/2022 - 03/2019
1	Glycemic Control 12/2023
1	Surgical Amputation (Amputations) 03/2023
1	Renal Dialysis (Hemodialysis) 03/2023
1	Debridement 01/2023
1	Replantation 01/2023
1	Sutures (Suture) 01/2023
1	Cardiac Resynchronization Therapy 12/2022
1	Catheters 03/2019
1	Immunotherapy 09/2017